Please login to the form below

Not currently logged in
Email:
Password:

Cello Health appoints digital leaders in the US

Rick Lang and Craig Lipski join in senior roles

Cello Health Communications Rick Lang Craig Lipski 

Cello Health Communications has appointed Rick Lang (pictured left) and Craig Lipski to digital leadership roles at its US organisation.

Lang has been named senior vice president, digital in a role that hands his responsibility for the strategic vision of the firm's digital capability.

He joins Cello from Huntsworth Health agency ApotheCom, where he served as senior vice president, digital for two and a half years, and prior spent three and a half years as vice president, communications technology at Huntsworth's The APO Group.

Lang said: “The word digital has so quickly come and gone as a focus. The tools and experiences that were once labelled as digital, simply because of novelty, are now the fabric of the world we live in. 

“I am so excited to be part an organisation that is appropriately concentrated on the one capability that truly differentiates, with evidence at our core and a sole focus on strategic content development.”

Meanwhile Lipski also arrives at Cello from ApotheCom, where he was senior director, application development. 

In his new role Lipski will be responsible for leading the interactive arm of the Cello Health Communications digital capability.

John Howley, managing director at Cello Health Communications - MedErgy, said: “Adding the expertise that Rick and Craig bring to the organization will allow us to leverage our strength in developing highly scientific content into new offerings to more effectively engage our clients' stakeholders to drive behavioural change.”

15th August 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios - Medical Animation

MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...